Research, Charts & Company Announcements
Research Tree provides access to ongoing research coverage, media content and regulatory news on KONINKLIJKE BAM GROEP NV. We currently have 6 research reports from 1 professional analysts.
Frequency of research reports
Research reports on
KONINKLIJKE BAM GROEP NV
KONINKLIJKE BAM GROEP NV
Disappointing set of figures: group's overheads drove the bottom line
28 Feb 17
Key information: • Revenue decreased by 6.0%. • Adjusted result before tax increased by 16.4%. • Adjusted result before tax margin improved by 30bp to 1.5%. • Dividend per share rose to €0.09 from €0.02. • Order book contracted by 11.3%.
Back in Shape programme delivers
23 Feb 16
h2. Key information : • Revenue increased by 1.5% to €7,423m and excluding FX effect decreased by 2%. • Adjusted results before tax increased by 42% to €88.2m. • Lower restructuring and impairment expenses compared to FY2014. • Net result of €10.2m vs €-108.2m in FY2014. • Order book increased by 12% to €11.5bn. • Dividend proposal of 2 cents per share. • Back in Shape programme completed. • Updated strategy for 2016-20.
Royal BAM on track to deliver cost savings of €100m
05 Nov 15
Key information: • 9m revenue up 3.8% to €5,359m. • 9m adjusted result before tax up from €15.1m to €45.7m. • Order book increased by 2% to €10.5bn. • Recourse net cash position at €172m versus recourse net debt position at €142m in Q3 14. • Trade working capital improved to -7.8% of sales versus -6% at year-end 2014.
Better than expected results, cash flow improvements
21 Aug 15
Key information: • Revenue increased by 3.9%. • EBIT at €-5.7m in H1 15 vs €-17.6m in H1 14. • EBIT margin at -0.1% in H1 15 vs -0.5% in H1 14. • Net result in positive territory whereas it was in negative territory in H1 14. • Order book increased by 3.7%. • Cash flow from operating activities at €-267.9m in H1 14 vs €-423.7m in H1 15.
N+1 Singer - Morning Song 21-03-2017
21 Mar 17
accesso Technology (ACSO LN) Full year results in line, but key trading months still ahead | Augean (AUG LN) Double digit growth in ’16, good start to ‘17 | Earthport (EPO LN) Interims show continued top line strength | Goals Soccer Centres (GOAL LN) Good momentum under new team. It’s now all about delivery | IQE (IQE LN) FY’16 results prompt further upgrades | Microsaic Systems (MSYS LN) Challenges in 2016, strategy remains in place | mporium Group (MPM LN) Funds raised to help execute strategy | RhythmOne (RTHM LN) Dawn of the independents | ScS Group (SCS LN) Strong progress on key growth initiatives albeit comps now toughen | Sinclair Pharma (SPH LN) FY results: EBITDA ahead, Instalift™ gaining pace | Vectura Group (VEC LN) FY (9-month) results
N+1 Singer - Augean - Double digit growth in ’16, good start to ‘17
21 Mar 17
Augean reported another year of double digit growth for 2016, with profits in line with our forecasts. Sales grew by 21% excluding landfill tax, while adjusted PBT grew by 18% to £7.1m before amortisation of acquired intangibles. DPS was increased by 54% to 1.0p, 25% ahead of our estimate. The business units made further strategic progress, with revenues from their top 20 customers increasing from 42% to 43% of the total, of which 88% was under contract or a framework agreement, increasing forward visibility. There has been an encouraging start to 2017 and management is confident of delivering another year of profits growth. The shares trade on undemanding single digit multiples, offering good value.